Diagnostic and Therapeutic Applications of Microarrays in Lung Transplantation
ConditionLung Transplant Rejection
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Alberta
About this trial
Objective: To evaluate the potential impact of molecular phenotyping of transbronchial biopsies in lung transplant recipients with allograft dysfunction, and the potential for developing a safer endobronchial mucosal biopsy format.
Eligibility criteria
Qualifiers
All lung transplant recipients undergoing a biopsy as determined by their surgeon or physician.
Disqualifiers
Patients who declined participation or unable to give informed consent.
Trial design
Treatments tested in this trial
- Lung transplant biopsy bites.
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov